title: Comment on: the cost effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe.
authors.forename: David Ian
authors.initials: DI
authors.lastname: Campbell
mesh_terms: D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000517:prevention & control*; D005060:Europe / Q000453:epidemiology; D005767:Gastrointestinal Diseases / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D006801:Humans; D010359:Patient Readmission / Q000191:economics / Q000706:statistics & numerical data*; D011634:Public Health; D012141:Respiratory Tract Infections / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D012400:Rotavirus Infections / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control; D022243:Rotavirus Vaccines / Q000191:economics*; D014611:Vaccination / Q000191:economics*
chemical_list: D022243:Rotavirus Vaccines